You can buy or sell Exact Sciences and other stocks, options, ETFs, and crypto commission-free!
Exact Sciences Corporation Common Stock, also called Exact Sciences, is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. Read More The company was founded on February 10, 1995 and is headquartered in Madison, WI.
52 Week High
52 Week Low
EXAS Crosses Above Average Analyst Target
In recent trading, shares of EXACT Sciences Corp. (Symbol: EXAS) have crossed above the average analyst 12-month target price of $101.12, changing hands for $101.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher - if things are looking up for the...
Markets InsiderMay 2
Exact Sciences' Journey From $11 To $101
(RTTNews) - Shares of Exact Sciences Corporation (EXAS) touched an all-time high of $101 in intraday trading on Wednesday, and that reflects an impressive 63% gain in just four months.
Expected Jul 31, After Hours